Skip to main content
. 2018 Aug 30;27(2):465–478. doi: 10.1007/s12350-018-1407-4

Table 3.

Fleiss’ kappa results (values and category of agreement)

Parameter Experts Participants
Phase 1 Phase 2 Phase 1 Phase 2
Function 0.55 (moderate) 0.47 (moderate) 0.38 (fair) 0.42 (moderate)
Perfusion 0.67 (substantial) 0.71 (substantial) 0.39 (fair) 0.49 (moderate)
PHR 0.41 (moderate) 0.41 (moderate) 0.33 (fair) 0.49 (moderate)
TID 0.41 (moderate) 0.34 (fair) 0.28 (fair) 0.41 (moderate)
SDS strat 0.50 (moderate) 0.52 (moderate) 0.19 (slight) 0.38 (fair)

PHR, patient high risk; TID, transient ischemic dilation; SDS strat, stratification of perfusion defects